Fort Sheridan Advisors LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1606666 HIGHLAND PARK, IL

Position in ALNY

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$562,809

-$113,593 QoQ

Shares Held

1,701

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fort Sheridan Advisors LLC holds $2,120,562 across 5 Biotechnology names. ALNY ranks #3 (26.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,674	$747,507
2	MGTX	MeiraGTx Holdings plc	66,860	$579,007
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,701	$562,809
4	REGN	Regeneron Pharmaceuticals, Inc.	280	$216,339
5	GERN	Geron Corp	10,000	$14,900

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$562,809	1,701	0.0%	Shares	Sole	2026-05-06
2025-12-31	$676,402	1,701	0.0%	Shares	Sole	2026-02-10
2025-09-30	$775,656	1,701	0.0%	Shares	Sole	2025-11-13
2025-06-30	$554,679	1,701	0.0%	Shares	Sole	2025-08-13
2025-03-31	$459,304	1,701	0.0%	Shares	Sole	2025-05-01
2024-12-31	$400,262	1,701	-1.8%	Shares	Sole	2025-02-05
2024-09-30	$476,626	1,733	0.0%	Shares	Sole	2024-11-14
2024-06-30	$421,119	1,733	+60.8%	Shares	Sole	2024-08-13
2023-12-31	$206,339	1,078	0.0%	Shares	Sole	2024-02-14
2023-06-30	$204,755	1,078	0.0%	Shares	Sole	2023-08-01
2023-03-31	$215,944	1,078	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.